Research & Innovation

Technology

Interpenetrated Networks --- Cross-Linked Technology

Optimizes the density of chemical nodes within the single-phase whilst minimizing the use of cross-linking agent (BDDE), thereby generating improved duration of NASViTA® in the tissue. Preserves the partial independence of the interpenetrated networks guaranteeing an easy and regular injection and a perfect insertion in the injection site by means of weak inter-network bonds - no migration of product and a smooth result.

Biphasic Technology & NASHA -- Non Animal Stabilized Hyaluronic Acid

NASViTA®’ patented Biphasic technology provide uniform particle size for consistency natural results. NASHA is the patented non-animal stabilized hyaluronic acid technology that creates a stabilized HA for reliable aesthetic treatments with a proven safety record. HASHA creates a precise, firmer gel texture intended for a more pronounced lift and targeted product integration.

Monophasic Technology

NASViTA® L-Plus VOLUMIZER dermal filler use monophasic cross-linking technology, which is a three-dimensional network structure. Excellent cohesion enables no tendency of the filler to disperse and flow in water and body fluids, achieving higher stability and best volumizing and contouring, perfect or filling in hollowed cheeks and chin with long-lasting results more than 18 months.

Bio Balance Technology

Bio Balance Technology produces an isoosmotic gel that allows: no edema, immediate vision of the correction without the need for over correction.

Security